RFPI Inc., a Greenville-based company that specializes in non-invasive medical imaging, raised $868,741 in debt, according to a Securities and Exchange Commission filing.

RFPI filed the Form D on March 22. According to the filing, the company must raise $131, 259 more to sell its total offering amount.

The company intends to use the proceeds as payments of salary.

RFPI is pioneering medical imaging technologies to improve surgical outcomes, reduce health-care costs, repeat surgeries and hospital readmissions, and enhance patient care.

The company’s patented and copyrighted intellectual properties propelled the creation of its iCertainty platform, which is the first medical imaging device to show blood flow without interrupting a surgical procedure or requiring injections, dyes, radiation or direct patient contact.

In January 2019, the company announced that it received 510(k) clearance from the U.S. Food and Drug Administration to begin marketing for use by surgeons in open surgery its iCertainty blood flow and perfusion imaging medical device.

A 510(k) is a premarket submission made to the FDA to demonstrate that the device to be marketed is at least as safe and effective, that is, substantially equivalent, to a legally marketed device that is not subjected to premarket approval.

The company closed on its Series A round of financing in May 2017 and is securing Series B financing now to commercialize iCertainty and market it to surgeons and medical centers.

“iCertainty has the potential to permanently change non-invasive medical imaging,” CEO Jeffery Basham said in a statement. “It’s exciting to bring to market new technology that delivers in terms of safety and patient and surgeon benefits.”

Companies relying on a Reg D exemption do not have to register their offering of securities with the SEC, but they must file what’s known as a Form D electronically with the SEC after they first sell their securities.

The form can be found here.